Palumbo et al., 2007 - Google Patents
Genetic analysis of hemostatic factors and cancerPalumbo et al., 2007
- Document ID
- 12674724866733389505
- Author
- Palumbo J
- Mullins E
- Degen J
- Publication year
- Publication venue
- Cancer-associated thrombosis
External Links
Snippet
A link between cancer and the hemostatic system was fi rst recognized more than a century ago with the observation that cancer patients are prone to hemostatic derangements, such as thrombophlebitis and disseminated intravascular coagulation. Malignant human and …
- 230000002439 hemostatic 0 title abstract description 42
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6437—Coagulation factor VIIa (3.4.21.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Levi | Inflammation and coagulation | |
Unruh et al. | Beyond thrombosis: the impact of tissue factor signaling in cancer | |
Stamenkovic | Extracellular matrix remodelling: the role of matrix metalloproteinases | |
Pepper | Role of the matrix metalloproteinase and plasminogen activator–plasmin systems in angiogenesis | |
Semeraro et al. | Coagulopathy of acute sepsis | |
Ruf et al. | Thrombin generation and the pathogenesis of cancer | |
Palumbo | Mechanisms linking tumor cell–associated procoagulant function to tumor dissemination | |
Levi | Disseminated intravascular coagulation in cancer patients | |
Versteeg et al. | New fundamentals in hemostasis | |
Esmon | The interactions between inflammation and coagulation | |
Rakic et al. | Role of plasminogen activator-plasmin system in tumor angiogenesis | |
Levi et al. | Sepsis and disseminated intravascular coagulation | |
Arnout et al. | Haemostasis | |
Schouten et al. | Inflammation, endothelium, and coagulation in sepsis | |
Oikonomopoulou et al. | Interactions between coagulation and complement—their role in inflammation | |
Levi et al. | Systemic versus localized coagulation activation contributing to organ failure in critically ill patients | |
Zhai et al. | Annexin A2 promotes glioma cell invasion and tumor progression | |
Palumbo et al. | Mechanisms linking tumor cell-associated procoagulant function to tumor metastasis | |
Levi | Management of cancer-associated disseminated intravascular coagulation | |
Garzón-Tituaña et al. | The multifaceted function of granzymes in sepsis: some facts and a lot to discover | |
Gordon | Cancer cell procoagulants and their role in malignant disease | |
Ruf | Tissue factor and PAR signaling in tumor progression | |
Van Dreden et al. | The role of tissue factor in cancer-related hypercoagulability, tumor growth, angiogenesis and metastasis and future therapeutic strategies | |
Nijziel et al. | From Trousseau to angiogenesis: the link between the haemostatic system and cancer | |
Espana et al. | The multifunctional protein C system |